Magellan Bioanalytics provides healthcare companies precision medicine solutions by identifying which patients will benefit from oncology drugs using our proprietary serum proteome analytics technology. Healthcare companies avoid the costs of overprescribing costly drug treatments and patients more rapidly move to a more appropriate treatment.